Key result
This review examines existing evidence on the use of electrophysiology testing for risk stratification of ischaemic patients with reduced left ventricular function.
Why the study?
Does electrophysiology testing improve risk stratification for sudden cardiac death compared to LVEF alone in patients with ischaemic cardiomyopathy?
Does electrophysiology testing improve risk stratification for sudden cardiac death compared to LVEF alone in patients with ischaemic cardiomyopathy?
This review highlights the potential limitations of using LVEF as the sole criterion for ICD indication and explores the role of electrophysiology testing for better risk stratification in ischaemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
LVEF-based ICD selection warrants caution due to limited arrhythmic specificity; leaves open whether electrophysiology testing refines primary prevention risk stratification.
Katritsis et al. (2017) conducted a review in Ischaemic cardiomyopathy. Electrophysiology testing was evaluated on Arrhythmic vs. non-arrhythmic cardiac death. This review examines existing evidence on the use of electrophysiology testing for risk stratification of ischaemic patients with reduced left ventricular function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: